Sign In
Buy BBP
$84.48
+0.92 (+1.10%)
At Close: Jun 03, 2026
Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal
09:42pm, Friday, 05'th Aug 2022
Biotechnology sector-related exchange traded funds continued to rally Friday on reports that Pfizer Inc. (NYSE: PFE) is looking to acquire Global Blood Therapeutics (NasdaqGS: GBT). On Friday, the Vir
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics
06:51pm, Thursday, 04'th Aug 2022
Global Blood Therapeutics (NasdaqGS: GBT) shares climbed Thursday, lifting biotechnology sector-related exchange traded funds, on speculation of takeover bids for the small drug developer. On Thursday
5 ETFs Riding High on the Biotech Comeback
12:25pm, Friday, 08'th Jul 2022
Biotech, the downtrodden segment of the market, has made a solid comeback on bargain hunting.
Biotech ETFs Are Making a Comeback
09:16pm, Tuesday, 05'th Jul 2022
Biotechnology stocks and sector-related exchange traded funds have been gaining momentum as investors return to this downtrodden segment of the market. Over the past month, the Virtus LifeSci Biotech
Biotech ETFs That Outperformed Last Week
01:46pm, Monday, 20'th Dec 2021
Biotech ETFs was the biggest gainer last week.
Healthcare Emerges as Best Sector of Last Week: 5 Top ETFs
09:13am, Monday, 20'th Dec 2021
Wall Street was downbeat last week with all indexes in the red. Still, Healthcare sector emerged as a key winner last week.
Biotech Innovations Remain At Forefront
11:10am, Friday, 16'th Apr 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r
Moving Beyond COVID In Biopharma
09:31am, Thursday, 15'th Apr 2021
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,
Best And Worst Q1 2021: Healthcare ETFs And Mutual Funds
10:49am, Wednesday, 03'rd Feb 2021
Best And Worst Q1 2021: Healthcare ETFs And Mutual Funds
The Reopening Killed The V-Shaped Recovery
07:43am, Monday, 29'th Jun 2020
This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
The 3 Cs Of Trading Markets In Turmoil
08:11pm, Thursday, 12'th Mar 2020
Here’s something to take some of the sting out of hard investing decisions. I call it the 3 Cs of trading in a crisis. Capital. Conviction. Courage. In order to
Will These Tech Stock Valuations Last?
01:06pm, Thursday, 13'th Feb 2020
Despite the coronavirus concerns that have hit commodity markets and, in turn, energy and basic materials stocks, U.S. tech stocks have posted strong returns to
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
02:35pm, Monday, 10'th Feb 2020
US healthcare is always a political hot potato, and volatility is expected to rise as the November elections approach. The US healthcare sector traded at a pric
EQRx's Challenge, And My Challenge To Them
01:15pm, Thursday, 16'th Jan 2020
EQRx's plan is apparently to come up with new competing pharmaceuticals in existing categories and sell them for lower prices than the patented ones. Insurance
A Guide to Biotech ETF Investing
07:40pm, Monday, 02'nd Dec 2019
Increasing M&A; deals, growing AI dominance and favorable regulatory tidings continue to work in favor of the biotech market.
